Research Summary
Anti-obesity prescription drugs are medications that are prescribed by doctors to people who are obese or overweight in order to help them lose weight by suppressing the appetite or reducing the absorption of fat in the body. These drugs work by changing the way the body processes food and nutrients, and may also cause changes in metabolism and energy levels. Some common anti-obesity prescription drugs include phentermine, liraglutide, orlistat, and Belviq. These drugs are typically used in combination with diet and exercise to achieve maximum weight loss results.
According to DIResearch's in-depth investigation and research, the global Anti-Obesity Prescription Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Anti-Obesity Prescription Drugs include F Hoffmann La Roche Ltd, Orexigen Therapeutics, Novo Nordisk A/s, Arena Pharmaceuticals, Glaxosmithkline, Vivus, Boehringer Ingelheim, Alizyme etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Anti-Obesity Prescription Drugs. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Anti-Obesity Prescription Drugs market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Anti-Obesity Prescription Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Anti-Obesity Prescription Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Anti-Obesity Prescription Drugs Include:
F Hoffmann La Roche Ltd
Orexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Boehringer Ingelheim
Alizyme
Anti-Obesity Prescription Drugs Product Segment Include:
Pediatric
Adult
Anti-Obesity Prescription Drugs Product Application Include:
Hospitals Pharmacies
Retail Pharmacies
E-commerce
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Anti-Obesity Prescription Drugs Industry PESTEL Analysis
Chapter 3: Global Anti-Obesity Prescription Drugs Industry Porter's Five Forces Analysis
Chapter 4: Global Anti-Obesity Prescription Drugs Major Regional Market Size and Forecast Analysis
Chapter 5: Global Anti-Obesity Prescription Drugs Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Anti-Obesity Prescription Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Anti-Obesity Prescription Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Anti-Obesity Prescription Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Anti-Obesity Prescription Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Anti-Obesity Prescription Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Anti-Obesity Prescription Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Anti-Obesity Prescription Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Anti-Obesity Prescription Drugs Market Overview 1.1 Product Definition and Statistical Scope 1.2 Anti-Obesity Prescription Drugs Product by Type 1.2.1 Global Anti-Obesity Prescription Drugs Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Pediatric 1.2.3 Adult 1.3 Anti-Obesity Prescription Drugs Product by Application 1.3.1 Global Anti-Obesity Prescription Drugs Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Hospitals Pharmacies 1.3.3 Retail Pharmacies 1.3.4 E-commerce 1.4 Global Anti-Obesity Prescription Drugs Market Revenue Analysis (2019-2030) 1.5 Anti-Obesity Prescription Drugs Market Development Status and Trends 1.5.1 Anti-Obesity Prescription Drugs Industry Development Status Analysis 1.5.2 Anti-Obesity Prescription Drugs Industry Development Trends Analysis 2 Anti-Obesity Prescription Drugs Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Anti-Obesity Prescription Drugs Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Anti-Obesity Prescription Drugs Market Analysis by Regions 4.1 Anti-Obesity Prescription Drugs Overall Market: 2023 VS 2024 VS 2030 4.2 Global Anti-Obesity Prescription Drugs Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Region (2019-2024) 4.2.2 Global Anti-Obesity Prescription Drugs Revenue Forecast by Region (2025-2030) 5 Global Anti-Obesity Prescription Drugs Market Size by Type and Application 5.1 Global Anti-Obesity Prescription Drugs Market Size by Type 5.2 Global Anti-Obesity Prescription Drugs Market Size by Application 6 North America 6.1 North America Anti-Obesity Prescription Drugs Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Anti-Obesity Prescription Drugs Market Size by Type 6.4 North America Anti-Obesity Prescription Drugs Market Size by Application 6.5 North America Anti-Obesity Prescription Drugs Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Anti-Obesity Prescription Drugs Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Anti-Obesity Prescription Drugs Market Size by Type 7.4 Europe Anti-Obesity Prescription Drugs Market Size by Application 7.5 Europe Anti-Obesity Prescription Drugs Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Anti-Obesity Prescription Drugs Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Anti-Obesity Prescription Drugs Market Size by Type 8.4 China Anti-Obesity Prescription Drugs Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Anti-Obesity Prescription Drugs Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Anti-Obesity Prescription Drugs Market Size by Type 9.4 APAC (excl. China) Anti-Obesity Prescription Drugs Market Size by Application 9.5 APAC (excl. China) Anti-Obesity Prescription Drugs Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Anti-Obesity Prescription Drugs Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Anti-Obesity Prescription Drugs Market Size by Type 10.4 Latin America Anti-Obesity Prescription Drugs Market Size by Application 10.5 Latin America Anti-Obesity Prescription Drugs Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Anti-Obesity Prescription Drugs Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Anti-Obesity Prescription Drugs Market Size by Type 11.4 Middle East & Africa Anti-Obesity Prescription Drugs Market Size by Application 11.5 Middle East & Africa Anti-Obesity Prescription Drugs Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Anti-Obesity Prescription Drugs Market Revenue by Key Manufacturers (2020-2024) 12.2 Anti-Obesity Prescription Drugs Competitive Landscape Analysis and Market Dynamic 12.2.1 Anti-Obesity Prescription Drugs Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 F Hoffmann La Roche Ltd 13.1.1 F Hoffmann La Roche Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Portfolio 13.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Orexigen Therapeutics 13.2.1 Orexigen Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Portfolio 13.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Novo Nordisk A/s 13.3.1 Novo Nordisk A/s Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Portfolio 13.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Arena Pharmaceuticals 13.4.1 Arena Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Portfolio 13.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Glaxosmithkline 13.5.1 Glaxosmithkline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Glaxosmithkline Anti-Obesity Prescription Drugs Product Portfolio 13.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Vivus 13.6.1 Vivus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Vivus Anti-Obesity Prescription Drugs Product Portfolio 13.6.3 Vivus Anti-Obesity Prescription Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Boehringer Ingelheim 13.7.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Portfolio 13.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Alizyme 13.8.1 Alizyme Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Alizyme Anti-Obesity Prescription Drugs Product Portfolio 13.8.3 Alizyme Anti-Obesity Prescription Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Anti-Obesity Prescription Drugs Industry Chain Analysis 14.2 Anti-Obesity Prescription Drugs Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Anti-Obesity Prescription Drugs Typical Downstream Customers 14.4 Anti-Obesity Prescription Drugs Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support